Elisabeth Bolton-Gillespie

Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.

Martin C. Müller, T. Holyoake, H. Klein, 2013, Blood.

Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.

O. Hantschel, M. Wasik, G. Hoser, 2016, Blood.

Normal ABL 1 is a Tumor Suppressor and Therapeutic Target in Human and Mouse Leukemias Expressing Oncogenic ABL 1 kinases Short title : ABL 1 is a tumor suppressor and therapeutic target

M. Wasik, G. Hoser, T. Skorski, 2016 .

Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells

S. Bhatia, K. Matlawska-Wasowska, M. Wasik, 2018, Cell reports.

Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells

L. Bullinger, J. Dick, K. Eppert, 2017, The Journal of clinical investigation.

Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expression

G. Wertheim, P. Raman, N. Speck, 2017, The Journal of experimental medicine.